73 results on '"Liao, Wen-Ting"'
Search Results
2. Discovery and Characterization of Genes Conferring Natural Resistance to the Antituberculosis Antibiotic Capreomycin
3. Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
4. Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
5. Supplementary Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
6. Supplementary Data from Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
7. Supplementary Data from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
8. Supplementary Figure 4 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
9. Supplementary Figure 3 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
10. Supplementary Data from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
11. Supplementary Figure 1 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
12. Supplementary Figure 4 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
13. Supplementary Figure 1 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
14. Supplementary Data from HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression
15. Supplementary Figure 2 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
16. Supplementary Figure 2 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
17. Supplementary Figure 3 from microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2
18. Supplementary Data from HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression
19. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
20. Effects of interleukin 1β on long noncoding RNA and mRNA expression profiles of human synovial fluid derived mesenchymal stem cells
21. Single‐cell profiling reveals novel cellular heterogeneity of monocytes during Hymenoptera venom allergy
22. Histone deacetylase inhibitors attenuated interleukin-1β-induced chondrogenesis inhibition in synovium-derived mesenchymal stem cells of the temporomandibular joint
23. Effects of Interleukin-1β on Long Noncoding RNA and mRNA Expression Profiles of Human Synovial Fluid-derived Mesenchymal Stem Cells
24. Retraction Note to: High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer
25. Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
26. Telomere dysfunction activates YAP1 to drive tissue inflammation
27. Abstract IA01: Modeling and understanding tumor biologic mechanisms
28. Abstract IA27: Context-dependent role of KRAS in GI malignancies
29. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
30. Single-Cell Multiomics and Immune Repertoire Features Identify Adalimumab-Sensitive Immune Cells During Ankylosing Spondylitis
31. Abstract A09: CD4 T cells mediated protumorigenic pathway in pancreatic cancer
32. Abstract LB-290: Telomere dysfunction is a driver of inflammatory bowel disease
33. Abstract LB-290: Telomere dysfunction is a driver of inflammatory bowel disease
34. UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
35. UHPLC-QTOFMS-Based Metabolomic Analysis of the Hippocampus in Hypoxia Preconditioned Mouse
36. Metabonomics Profiling Reveals Biochemical Pathways Associated with Pulmonary Arterial Hypertension in Broiler Chickens
37. Marketing Texas Wine: Determining the Who, What, and Where of a Growing Market
38. Downregulation of SAFB Sustains the NF-κB Pathway by Targeting TAK1 during the Progression of Colorectal Cancer
39. Marketing Texas Wine: Determining the Who, What, and Where of A Growing Market
40. miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1
41. Elevated pentose phosphate pathway is involved in the recovery of hypoxia-induced erythrocytosis
42. Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
43. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
44. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
45. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42
46. RETRACTED ARTICLE: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
47. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression
48. Metabolite Modulation in Human Plasma in the Early Phase of Acclimatization to Hypobaric Hypoxia
49. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway
50. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.